| abstract |
The present invention, in its many embodiments, includes certain pyrazolo [1,5-a] pyrimidine compounds of formula (I) that may have utility as inhibitors of cyclin dependent kinases (“CDKs”) and Methods for preparing such compounds are provided. The compounds may have potential utility for the treatment, prevention, inhibition or amelioration of one or more diseases associated with CDK. The compounds of the present invention may also be useful in the treatment of neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases. |